Trial intelligence / Profile preview

Exploratory study of nicotinic acid on subcutaneous adipose tissue inflammation in obesity

2009-012124-85Phase 2Active

Sponsor
Centre hospitalier universitaire de Toulouse
Start
Aug 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, open-label trial of niacin in obesity (2 arms), sponsored by Centre hospitalier universitaire de Toulouse. Primary endpoint: Change in adipose tissue inflammation. Started Aug 2009; status: active.

02

Drugs

niacin
03

Conditions

obesity

Beyond the preview

Go deeper on 2009-012124-85.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-012124-85.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call